Role of Stem Cell Reprogramming Factor Uncovered
Mouse embryonic fibroblasts undergoing reprogramming. Credit: Dina Faddah
A little over 10 years ago, the first reprogramming of adult cells into undifferentiated stem cells was achieved. These induced pluripotent stem cells (iPSCs) have the ability to become almost any cell type and can divide indefinitely, so share many features with embryonic stem cells. Such characteristics enable iPSCs to be used in several applications of regenerative medicine, particularly because they can be derived from an individual’s own cells so tissue rejection problems are not encountered. They can also be programmed to develop into rare or inaccessible cell types, used to screen novel drugs, and studied to understand the cellular basis of disease or reprogramming.
However, while the genetic factors responsible for reprogramming are well known, the mechanisms underlying the responses to induced gene expression changes are not as clear.
Now, research led by the University of Tsukuba has solved the mystery surrounding one of the reprogramming factors, KLF4.
KLF4 together with other reprogramming transcription factors is used in the lab to force the expression of genes in somatic cells (adult non-germline cells) in the development of iPSCs. Somatic cells generate their energy in an oxygen-fueled process called oxidative phosphorylation, which takes place in the mitochondria, also known as cellular powerhouses.
In contrast, stem cells have small mitochondria and use glycolysis as an alternative biochemical pathway to generate energy. This series of reactions can be anaerobic, so more suited to their typically low-oxygen environment, but also provides the supply of metabolic intermediates necessary for rapid growth and division.
University of Tsukuba researchers developed a gene transfer system that allowed iPSC reprogramming to only occur in the presence of KLF4, thus focusing exclusively on its role in the process. They then used genome-wide analysis to search for genes switched on by KLF4 at a late stage of reprogramming.
"We found that the Tcl1 gene was upregulated by KLF4 binding to its enhancer and promoter regions," study co-first author Ken Nishimura says. "KLF4 also caused the binding of another reprogramming factor, OCT4, to the Tcl1 promoter."
The team discovered that the TCL1 protein played a key role in increasing glycolysis by activating a different metabolic pathway that is important for the self-renewal of stem cells.
"We also showed that TCL1 inhibits a mitochondrial enzyme required for in oxidative phosphorylation, leading to a reduction in oxygen consumption of the cells", co-first author Shiho Aizawa explains. "This was matched by increased glucose uptake for glycolysis, revealing that TCL1 promotes the metabolic switch in energy generation necessary for cells to acquire pluripotency."
Nishimura, K., Aizawa, S., Nugroho, F. L., Shiomitsu, E., Tran, Y. T., Bui, P. L., . . . Hisatake, K. (2017). A Role for KLF4 in Promoting the Metabolic Shift via TCL1 during Induced Pluripotent Stem Cell Generation. Stem Cell Reports. doi:10.1016/j.stemcr.2017.01.026
This article has been republished from materials provided by University of Tsukuba. Note: material may have been edited for length and content. For further information, please contact the cited source.
DNA ‘Shield’ Discovered with Crucial Roles in Normal Cell Division, the Immune System & CancerNews
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.READ MORE
Regenerative Medicine Meets Clever Engineering to Accommodate Bone GraftsNews
Personalized bone grafts developed to repair bone defects from disease or injuryREAD MORE
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.